Jinjiao He

442 total citations
14 papers, 337 citations indexed

About

Jinjiao He is a scholar working on Genetics, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, Jinjiao He has authored 14 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Animal Science and Zoology and 6 papers in Epidemiology. Recurrent topics in Jinjiao He's work include Virus-based gene therapy research (9 papers), Animal Virus Infections Studies (8 papers) and Virology and Viral Diseases (4 papers). Jinjiao He is often cited by papers focused on Virus-based gene therapy research (9 papers), Animal Virus Infections Studies (8 papers) and Virology and Viral Diseases (4 papers). Jinjiao He collaborates with scholars based in China, United States and Iraq. Jinjiao He's co-authors include Yunye Liu, Guiping Ren, Deshan Li, Xiaochen Guo, Xinyu Gao, Yin-Hang Yu, Liying Song, Dehua Zou, Deshan Li and Fuliang Bai and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Jinjiao He

14 papers receiving 324 citations

Peers

Jinjiao He
Shahrokh M. Ghobadloo Canada
Ally Lau Singapore
Julianna S. Deakyne United States
Linfang Li China
Michael A. Salako United Kingdom
Brian S. Majors United States
В. П. Вейко Russia
Hyein Jung South Korea
Wenfu Ma China
Can Li China
Shahrokh M. Ghobadloo Canada
Jinjiao He
Citations per year, relative to Jinjiao He Jinjiao He (= 1×) peers Shahrokh M. Ghobadloo

Countries citing papers authored by Jinjiao He

Since Specialization
Citations

This map shows the geographic impact of Jinjiao He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjiao He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjiao He more than expected).

Fields of papers citing papers by Jinjiao He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjiao He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjiao He. The network helps show where Jinjiao He may publish in the future.

Co-authorship network of co-authors of Jinjiao He

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjiao He. A scholar is included among the top collaborators of Jinjiao He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjiao He. Jinjiao He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
He, Jinjiao, et al.. (2024). The influence of cigR gene on the pathogenicity of Salmonella paratyphi A in vitro and in vivo. FEMS Microbiology Letters. 371. 2 indexed citations
2.
He, Jinjiao, Ying An, Jianying Qi, et al.. (2020). The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model. Journal of Medical Virology. 93(6). 3890–3898. 12 indexed citations
3.
Li, Chengbo, Jinjiao He, Jijia Xie, et al.. (2019). Photocatalytic Hydrogen Production Based on a Serial Metal‐Salen Complexes and the Reaction Mechanism. ChemCatChem. 11(24). 6324–6331. 34 indexed citations
4.
Wu, Yunzhou, Jinjiao He, Jingshu Geng, et al.. (2017). Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy. European Journal of Pharmacology. 802. 85–92. 25 indexed citations
5.
He, Jinjiao, et al.. (2017). Use of viral vector to deliver IL-15 for cancer therapy: An Overview. 1 indexed citations
6.
Wu, Yunzhou, Jinjiao He, Ying An, et al.. (2016). Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy. Journal of Pharmacological Sciences. 132(1). 24–30. 33 indexed citations
7.
Yu, Yin-Hang, Jinjiao He, Siming Li, et al.. (2016). Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway. International Immunopharmacology. 38. 144–152. 135 indexed citations
8.
Xu, Pengfei, Yingjie Zhang, Liying Song, et al.. (2016). Efficacy of a combination of high and low dosage of PEGylated FGF-21 in treatment of diabetes in db/db mice. Biomedicine & Pharmacotherapy. 84. 97–105. 10 indexed citations
9.
He, Jinjiao, Yunye Liu, Jiarui Yang, et al.. (2016). Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect. PLoS ONE. 11(10). e0164723–e0164723. 10 indexed citations
10.
An, Ying, Jinjiao He, Rui Chen, et al.. (2016). Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model. Journal of Biomedical Science. 23(1). 55–55. 18 indexed citations
11.
He, Jinjiao, Guiyou Tian, Xin Liu, et al.. (2016). Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy. Virus Research. 221. 23–29. 8 indexed citations
12.
Ren, Guiping, Guiyou Tian, Yunye Liu, et al.. (2015). Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy. Technology in Cancer Research & Treatment. 15(5). NP83–NP94. 25 indexed citations
13.
Yu, Dan, Xianlong Ye, Qiang Wu, et al.. (2015). Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway. Endocrine. 52(3). 527–540. 15 indexed citations
14.
Wu, Yunzhou, Shijun Yan, Zheng Lv, et al.. (2013). Recombinant Newcastle Disease Virus Anhinga Strain (NDV/Anh-EGFP) for Hepatoma Therapy. Technology in Cancer Research & Treatment. 13(2). 169–175. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shahrokh M. Ghobadloo Breakdown of academic impact, for papers by Ally Lau Breakdown of academic impact, for papers by Julianna S. Deakyne Breakdown of academic impact, for papers by Linfang Li Breakdown of academic impact, for papers by Michael A. Salako Breakdown of academic impact, for papers by Brian S. Majors Breakdown of academic impact, for papers by В. П. Вейко Breakdown of academic impact, for papers by Hyein Jung Breakdown of academic impact, for papers by Wenfu Ma Breakdown of academic impact, for papers by Can Li
Rankless by CCL
2026